Foreign companies accused by Chinese regulators of fixing nutrition formula prices have settled for $110 million, closing a four month-long investigation by the National Development and Reform Commission. The fined companies include Mead Johnson Nutrition Co, Danone, New Zealand-based Fonterra, Netherlands-based cooperative FrieslandCampina, Hong Kong-based Biostime International, and Abbott Laboratories. Xinhua news agency reported that the fines beat a new record for China without elaborating on specifics. Antitrust expert Peter Wang told reporters that China “has typically not issued large fines for antitrust violations.” Foreign companies have recent lowered their prices in China for infant milk formula following allegations of price-fixing and other anticompetitive allegations.
Featured News
NBA Teams Up With US Regulator on Prediction Markets
Oct 27, 2026 by
CPI
Intesa Wins ECB Approval for $36 Billion Monte dei Paschi Takeover
Oct 27, 2026 by
CPI
PayPal, Revolut Weigh In as UK Targets Apple’s Tap-to-Pay Rules
Oct 27, 2026 by
CPI
Heineken Ordered to Pay $124 Million in Greek Antitrust Case
Oct 27, 2026 by
CPI
FTC Raises Antitrust Concerns Over Cintas’ $5.5 Billion Deal
Oct 27, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Exclusive Dealing
Oct 25, 2026 by
CPI
Exclusive Dealing Without Exclusivity: Screening Contracts, Loyalty Rebates, and the Limits of Antitrust Tests
Oct 25, 2026 by
David Martimort & Jérôme Pouyet
When Competition for Exclusivity Raises Prices: Rebates, Pricing Rules, and the Insulin Puzzle
Oct 25, 2026 by
Daniel P. O’Brien & Greg Shaffer
Why Leaving the Door Open Can Be (Much) Worse Than Closing It: Share-Based Requirements, Buyer-Specific Costs, and Foreclosure
Oct 25, 2026 by
Zhijun Chen & Greg Shaffer
Antitrust Chronicle® – EU Merger Guidelines
Oct 19, 2026 by
CPI